Michael Berger, PhD

Named Grant: The Dr. Peter J. Stambrook Award in Cancer Medicine

The goal of Dr. Berger’s research is to develop a new T cell for use in Adoptive Cell Transfer that will be able to effectively treat solid tumors. Dr. Berger’s team plans to create T cells that use a different form of sugar to power them because glucose-fueled T cells run out of energy in the glucose-deficient microenvironment of solid tumors. It is his hope that this simple improvement in metabolism will contribute to the transition of T- cell therapy from a promising treatment to an effective one.

View Grant Recipient profile